Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis

Phillip H. Kuo, Emanuel Kanal, Ali K. Abu-Alfa, Shawn E. Cowper

Research output: Contribution to journalReview articlepeer-review

499 Scopus citations


While at this time there are more questions than answers, the recognition of an epidemiologic association between the administration of gadolinium-based MR contrast agents and the development of nephrogenic systemic fibrosis prompts caution in the use of these agents in the setting of renal disease.

Original languageEnglish (US)
Pages (from-to)647-649
Number of pages3
Issue number3
StatePublished - Mar 2007

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis'. Together they form a unique fingerprint.

Cite this